Science/Research reporter

Lisa M. Krieger

Lisa M. Krieger is a Bay Area News Group science writer for The Mercury News and East Bay Times, covering research, scientific policy and environmental news from Stanford University, the University of California, NASA-Ames, U.S. Geological Survey and other Bay Area-based research facilities. She graduated from Duke University with a BA degree in biology. She splits her time between Palo Alto and Inverness, and in her spare time likes wildlife photography, swimming, skiing and backpacking.

Do our brains have the privacy they need? Neuralink's implant is announced with great fanfare, but few details.

SUBSCRIBER ONLY

Elon Musk's deep dive into human experimentation

February 8, 2024 at 10:34 a.m.

Do our brains have the privacy they need? Neuralink's implant is announced with great fanfare, but few details.

Tuberculosis, a global infectious disease killer, makes a surprise reappearance in California.

News |
Why TB cases are rising in California after decades of decline

February 1, 2024 at 12:33 p.m.

Tuberculosis, a global infectious disease killer, makes a surprise reappearance in California.

Cannabis growing in a field.

SUBSCRIBER ONLY

News |
Did legal marijuana help or harm Californians? Here’s what the data says

February 1, 2024 at 3:37 p.m.

Life changed after legalization in at least four different ways.

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment.

SUBSCRIBER ONLY

Long Covid creates changes in the blood, aiding detection, reports new study

January 19, 2024 at 12:27 p.m.

A shifting pattern of proteins, showing immune dysregulation, could help efforts to create diagnostic tests and treatment.

Japan suffered 0.1% the deaths -- 55 vs. 59,000 -- of Turkey. Why?

World News |
Why Japan's 7.6 quake wasn't Turkey’s tragedy all over again

January 4, 2024 at 10:53 a.m.

Japan suffered 0.1% the deaths -- 55 vs. 59,000 -- of Turkey. Why?

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

New psychedelic-like drugs: All treatment, no 'trip'?

December 13, 2023 at 11:18 a.m.

California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.

Biotech startups and venture capital funds are investing in once-controversial treatments.

Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs

December 13, 2023 at 11:21 a.m.

Biotech startups and venture capital funds are investing in once-controversial treatments.

Small samples of the cremated remains of scientist and astronaut Michael Lampton and 233 others will make eternal loops around the sun.

SUBSCRIBER ONLY

Rest in space: A California astronaut gets a celestial burial

November 27, 2023 at 2:41 p.m.

Small samples of the cremated remains of scientist and astronaut Michael Lampton and 233 others will make eternal loops around the sun.

Biotech entrepreneur Garry Nolan launches "Stardust Repository" and foundation to study Unidentified Aerial Phenomena.

SUBSCRIBER ONLY

National News |
How a Stanford professor is organizing the hunt for alien life

November 21, 2023 at 10:33 a.m.

Biotech entrepreneur Garry Nolan launches "Stardust Repository" and foundation to study Unidentified Aerial Phenomena.

Google's Sergey Brin and NASA's Alan Weston use new technologies to resurrect a long-forgotten way to fly.

SUBSCRIBER ONLY

Business |
How Silicon Valley will put airships back in flight

November 14, 2023 at 12:34 p.m.

Google's Sergey Brin and NASA's Alan Weston use new technologies to resurrect a long-forgotten way to fly.